Welcome to our dedicated page for AXO news (Ticker: AXO), a resource for investors and traders seeking the latest updates and insights on AXO stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AXO's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AXO's position in the market.
Axos Financial, Inc. (NYSE: AX) announced the redemption of all 6.25% Subordinated Notes due February 28, 2026, totaling $51 million. The redemption occurred on March 31, 2021, funded primarily by $175 million from newly issued 4.875% Fixed-to-Floating Rate Subordinated Notes due 2030. This move is expected to reduce annual interest expenses by approximately $3.2 million. Following the redemption, the 2026 Notes will no longer trade on the NYSE.
